6 Hedge Funds Killed By the Decline in Dendreon $DNDN

Six hedge funds lost a bundle because Dendreon, the maker of prostate cancer drug Provenge, declined 66% after revealing disappointing sales numbers. The stock lost more than $23.50 so far today. Here are the 6 hedge funds killed by the decline in Dendreon:

SAC CAPITAL ADVISORS

1. Steve Cohen – SAC Capital: Lost $193 Million

2. Brookside Capital – Bain Capital: Lost $111 Million

3. George Soros – Soros Fund Management: Lost $110 Million

4. Samuel Isaly – OrbiMed Advisors: Lost $32 Million

5. Ken Griffin – Citadel: Lost $23 Million

6. Israel Englander – Millennium Management: Lost $22 Million

You can see the rest of the losers here. These calculations assumed that these hedge funds didn’t increase or reduce their stock positions in Dendreon (DNDN) since the end of March. We also didn’t take into account their option positions.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!